Cardiff Oncology
CRDF
CRDF
77 hedge funds and large institutions have $45.8M invested in Cardiff Oncology in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% more funds holding
Funds holding: 55 → 77 (+22)
7.36% more ownership
Funds ownership: 11.88% → 19.25% (+7.4%)
Holders
77
Holding in Top 10
–
Calls
$4.67M
Puts
$325K
Top Buyers
| 1 | +$3.65M | |
| 2 | +$2.32M | |
| 3 | +$1.53M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.35M |
| 5 |
BC
BIT Capital
Berlin,
Germany
|
+$1.26M |
Top Sellers
| 1 | -$208K | |
| 2 | -$162K | |
| 3 | -$141K | |
| 4 |
Two Sigma Advisers
New York
|
-$93.5K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$49.5K |